Evidence map›Paper›PMID 40654947›Full record

ArticlebioRxiv : the preprint server for biology2025

Modeling human retinal ganglion cell axonal outgrowth, development, and pathology using pluripotent stem cell-based microfluidic platforms.

Cátia Gomes, Kang-Chieh Huang, Sailee S Lavekar, Jade Harkin, Carson Prosser, Yue Fang, Claire Kalem, Adrian Oblak, Chi Zhang, Jason S Meyer

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Cátia GomesDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0001-8491-6822
Kang-Chieh HuangStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202.
Sailee S LavekarStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202.
Jade HarkinDepartment of Biology, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202.
Carson ProsserDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202.
Yue FangDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202.
Claire KalemStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202.
Adrian OblakStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202.
Chi ZhangDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202.
Jason S MeyerDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0001-9037-6033

Funding

Overcoming Barriers to retinal ganglion cell replacement in experimental glaucomaU24EY033269 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI FORTUNE, BRAD, MEYER, JASON STEPHEN · 2021 to 2025
$7.0M
Establishing a human cellular model of retinal ganglion cell compartmentalization in neurodegeneration and neuroinflammationR01EY033022 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI Jason Stephen Meyer · 2021 to 2026
$2.7M
NEI NIH HHS R01 EY033022NEI NIH HHS U24 EY033269
6 · The paper itself

Abstract

Retinal ganglion cells (RGCs) are highly compartmentalized cells, with long axons serving as the sole connection between the eye and the brain. RGC degeneration in injury and/or disease also occurs in a compartmentalized manner, with distinct injury responses in axonal and somatodendritic compartments. Thus, the goal of this study was to establish a novel microfluidic-based platform for the analysis of RGC compartmentalization in health and disease states. Human pluripotent stem cell (hPSC)-derived RGCs were seeded into microfluidics, enabling the recruitment and isolation of axons apart from the somatodendritic compartment. Initial studies explored axonal outgrowth and compartmentalization of axons and dendrites. We then compared the differential response of RGCs differentiated from hPSCs carrying the OPTN(E50K) glaucoma mutation with isogenic control RGCs in their respective axonal and somatodendritic compartments, followed by analysis of axonal transport. Further, we explored the axonal transcriptome via RNA-seq, focusing on disease-related axonal differences. Finally, we established models to uniquely orient astrocytes along the axonal compartment combined with modulation of astrocyte reactivity as a pathological feature of neurodegeneration. Overall, RGC culture within microfluidic chips allowed enhanced cell growth and maturation, including long-distance axonal projections and proper compartmentalization, while patient-specific RGCs exhibited axonal outgrowth deficits as well as decreased rate of axonal transport. Finally, the induction of astrocyte reactivity uniquely along the proximal region of RGC axons led to the onset of neurodegenerative phenotypes in RGCs. These results represent the first study to effectively recapitulate the highly compartmentalized properties of hPSC-derived RGCs in healthy and disease states, providing a more physiologically relevant in vitro model for neuronal development and degeneration.

Indexed as

axonmicrofluidicretinal ganglion cellStem cell

Identifiers

PMID40654947
PMCPMC12248158

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.